Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Feb 28;6(14):12625–12636. doi: 10.18632/oncotarget.3470

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2015 de Miguel-Luken et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

A) Representative images of MAP17 immunostaining are shown for different larynx tumors. B) High magnification of M17 positive and negative tumors. The picture shows a magnification of the inset of figure A. C) A graph is shown representing the percentage of laryngeal tumors with dichotomous MAP17 levels. The score for positive tumors were >62. D) The distribution of the MAP17 expression levels among different grades of larynx tumors is shown. The MAP17 levels (score) refers to maximum levels (0–2) scored by the percentage of cells (0–100). The normalized levels were obtained by multiplying the percentage of cells by the level of intensity observed. Anova test was performed to establish the statistical association between MAP17 protein levels and the grade of the tumor (p<0,05).